Abstract
To highlight emerging adjunctive neuroprotective agents for treatment of hypoxic ischemic encephalopathy (HIE). HIE is a common cause of neonatal neurologic morbidity and mortality. Therapeutic hypothermia is a standard therapy, but neuroprotection is incomplete. There are several potential adjunctive agents that can be used to augment neuroprotection when combined with hypothermia. Several recent studies have evaluated the use of adjunctive therapies that, when used in combination with therapeutic hypothermia, may improve short- and long-term outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
